![]() |
|||||||||||||||||
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||||||||
|
![]() |
EID
Home | Ahead of Print | Past
Issues | EID Search | Contact
Us | Announcements | Suggested
Citation | Submit Manuscript
Volume 12, Number 5, May 2006 Isoniazid Preventive Therapy and Risk for Resistant TuberculosisMaria Elvira Balcells,* Sara L. Thomas,* Peter Godfrey-Faussett,*
and Alison D. Grant* |
|
|
![]() |
|
Back to article | |
Figure 1. Relative risk (RR) for isoniazid resistance associated with isoniazid preventive therapy in 13 studies. A) Using definition (a) of resistance for the Greenland study (20). B) Using definition (b) of resistance for the Greenland study. *Excluding the 4 studies with no resistant cases in 1 or both of the 2 groups. The squares and horizontal lines represent the relative risk (RR) and 95% confidence intervals (CIs) for each study. The diamonds represent the summary RR and 95% CIs. |
|
|
|
![]() |
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
![]() |
![]() |
This page last reviewed April 14, 2006 |
![]() |
![]() |
Emerging
Infectious Diseases Journal |
![]() |